Vertex Pharmaceuticals | VRTX - PE Price to Earnings

Stock Price
470.52
Daily Change
4.91 1.05%
Monthly
4.84%
Yearly
-3.67%
Q1 Forecast
455.43

Vertex Pharmaceuticals reported $23.93 in PE Price to Earnings for its fiscal quarter ending in September of 2025.





Pe Change Date
AbbVie USD 110.26 91.85 Sep/2025
Acadia Pharmaceuticals USD 13.7 2.49 Sep/2025
Agios Pharmaceuticals USD 2.88 0.36 Jun/2025
Amgen USD 9.49 3.02 Sep/2025
Biogen USD 9.38 3.02 Sep/2025
BioMarin Pharmaceutical USD 19.45 4.32 Sep/2025
Bristol-Myers Squibb USD 8.24 9.03 Sep/2025
Gilead Sciences USD 15.72 0.32 Sep/2025
Incyte USD 17.63 2.86 Sep/2025
Ionis Pharmaceuticals USD 396.15 79.28 Sep/2022
J&J USD 23.62 0.86 Dec/2025
Merck USD 8.84 0.26 Sep/2025
Moderna USD 27.22 14.51 Jun/2023
Neurocrine Biosciences USD 33.27 9.34 Sep/2025
Novartis USD 15.74 0.15 Sep/2025
Pfizer USD 9.3 1.57 Sep/2025
PTC Therapeutics USD 6.73 0.26 Sep/2025
Regeneron Pharmaceuticals USD 18.11 2.91 Dec/2025
Roche Holding CHF 16.09 3.51 Dec/2025
Sanofi EUR 11.99 1.58 Dec/2025
Sarepta Therapeutics USD 27.27 0 Jun/2025
United Therapeutics USD 15.7 4.24 Sep/2025
Vertex Pharmaceuticals USD 23.93 3.88 Sep/2025